Acute coronary syndrome (ACS) is the most lethal manifestation and frequent clinical ischemic heart disease (IHD), which persists as a major cause of morbidity and mortality both in Europe and in the rest of the world.
It is estimated that SCA produces 7.6 million deaths each year, of which more than 2 million are in Europe and more than 740,000 in the countries of the European Union.
Currently, ischemic heart disease is the first single cause of death in men and second in women. According to estimates, in 2021 the number of cases of acute coronary syndrome will stand at 109,772 and, for demographic reasons, will increase until 2049.
Notably, in 2006, with the entry into force of the first law on the prevention of passive smoking, the attack rate of acute myocardial infarction decreased by 11%.
Prognostic factors of SCA
Fortunately, in our country the number of people who survive an acute myocardial infarction is constantly rising thanks to the launch of Infarct Code along with the stabilization of the incidence rate in recent decades and the significant decrease in lethality short (28-30 days) and medium term (6 months). On the other hand, the progressive aging of our society also influences the progressive increase in the prevalence of CI, since most cases occur in individuals over 55 years.
Sex differences in the prognosis of AMI
During the 90s a number of scientific publications indicated that, although the incidence rate of AMI was lower in women than in men, short - term lethality was much higher in women.
Economic impact of AMI
In 2010, reports the British Heart Foundatio n indicated that cardiovascular disease in Europe posed spending on health services of 112 billion euros. Meanwhile, they bounded to the SCA figures were 25 billion euros. In Spain, the Ministry of Health estimated the annual cost of CI in € 326,140,000, of which 116,920,000 € were direct costs and indirect 209,220,000 € in 2006.
Estimates suggest a stabilization in the number of SCA in the group of 25-74 years and a significant increase in those over 74 years until 2049. The reason for this increase is the progressive aging of the population, that at this time the group of 25-74 years will increase by 9% while the older 74 years will grow by 110%. This increase undoubtedly result in greater health spending.
This increase in the number of acute coronary syndrome and its associated costs estimated for the coming decades might not be as high if preventive measures were implemented. Thus, the reduction in the prevalence of certain risk factors such as blood pressure, cholesterol levels and obesity could cushion the expected increase in the number of coronary events.
It is very important to visit a specialist in cardiology to detect possible pathologies.